object
time
implement
influenza
infect
control
treatment
significantli
reduc
impact
hospit
resourc
patient
manag
demand
peak
turnaround
time
laboratori
base
screen
test
diagnosi
influenza
may
impact
implement
infect
control
measur
treatment
studi
object
includ
determin
correl
abbott
id
pointofcar
test
poct
instrument
use
influenza
test
laboratori
base
genexpert
flursv
kit
addit
impact
poct
instrument
prescript
antivir
antibiot
evalu
compar
practic
instrument
place
result
correl
studi
cohort
patient
reveal
abbott
id
poct
sensit
detect
influenza
specif
influenza
b
impact
poct
instrument
frequenc
prescript
antivir
amount
antibiot
consum
reduct
antibiot
consumpt
cohort
signific
addit
averag
patient
length
hospit
stay
significantli
reduc
day
day
manag
patient
flow
bed
alloc
import
element
effect
infect
control
programm
viral
influenza
infect
effect
programm
requir
result
screen
test
avail
make
decis
time
manner
suit
flow
newli
admit
patient
hospit
difficult
laboratorybas
test
especi
weekend
even
limit
oncal
servic
may
avail
nick
enzym
nucleic
acid
near
isotherm
amplif
techniqu
enabl
rapid
amplif
narrow
temperatur
rang
elimin
need
thermal
cycler
hightemperatur
dna
denatur
cycl
requir
polymeras
chain
reaction
pcr
lowfootprint
benchtop
instrument
provid
result
min
nearpati
set
previous
demonstr
poct
lead
rapid
confirm
influenza
allow
inform
earli
decis
make
reduc
flu
contact
bed
closur
emerg
evid
suggest
less
invas
sampl
may
compar
sensit
nasopharyng
swab
aspir
use
molecular
diagnost
test
test
kit
util
nasal
swab
comfort
patient
eg
id
number
correspond
sjpoconnel
bonsecoursi
shannon
appli
biotechnolog
centr
institut
technolog
trale
trale
co
kerri
ireland
full
list
author
inform
avail
end
articl
studi
report
outlin
perform
aler
poct
known
abbott
id
naat
versu
laboratori
base
method
thermocycl
rtpcr
viral
cultur
influenza
test
studi
report
influenza
sensit
rang
specif
influenza
b
sensit
rang
specif
studi
compar
id
genexpert
previous
use
nasopharyng
swab
viral
transport
medium
vtm
sensit
report
lower
vtm
specimen
use
instead
direct
nasal
swab
assay
also
lower
sensit
sampl
determin
low
flu
titer
determin
higher
ct
valu
rtpcr
order
better
assist
patient
flow
bed
manag
winter
prospect
assess
util
poct
id
influenza
assay
test
compar
genexpert
platform
laboratori
set
addit
impact
antibiot
antivir
prescript
compar
determin
influenc
poct
servic
element
patient
manag
consecut
flu
season
preimplement
postimplement
infect
control
algorithm
suspect
influenza
implement
pre
post
poct
test
period
studi
outlin
supplementari
inform
context
outbreak
hospit
infect
control
algorithm
suspect
access
entri
suspect
influenza
pathway
occur
rule
pathway
match
patient
specimen
collect
medic
assess
unit
bon
secour
hospit
trale
co
kerri
ireland
met
hospit
clinic
algorithm
suspect
influenza
octob
april
mid
turbin
nasal
swab
puritan
steril
foam
tip
applic
ref
test
within
h
collect
prefer
specimen
id
poct
devic
nasal
throat
specimen
analysi
genexpert
collect
use
cepheid
xpert
nasopharyng
sampl
collect
kit
virus
ref
viral
transport
medium
vtm
specimen
test
genexpert
flursv
assay
typic
store
h
routin
day
h
weekend
prior
transport
referr
laboratori
test
poct
coordin
mau
nurs
staff
medic
senior
hous
offic
sho
train
manufactur
use
id
instrument
patient
posit
influenza
result
flag
standard
droplet
precaut
isol
infect
control
team
patient
specimen
analys
test
system
per
manufactur
instruct
batch
reagent
use
valid
studi
qualiti
control
receipt
specimen
test
abbott
id
assay
within
h
collect
analysi
patient
swab
use
genexpert
platform
referr
laboratori
carri
mix
equal
volum
aliquot
vtm
nasal
throat
specimen
test
give
aggreg
sampl
genexpert
method
provid
posit
result
either
nasal
throat
swab
posit
pool
sampl
collect
detail
result
specimen
analys
use
id
manual
record
influenza
specimen
analysi
report
compil
oper
subsequ
file
patient
medic
chart
specimen
analysi
use
genexpert
sent
patholog
depart
specimen
regist
laboratori
inform
system
isoft
transfer
courier
referr
laboratori
data
gather
hospit
li
patient
inform
manag
system
pim
isoft
retrospect
interrog
use
sap
busi
object
bi
platform
version
data
patient
specimen
collect
influenza
test
septemb
april
repres
pre
poct
test
data
set
data
patient
pointofcar
influenza
test
septemb
april
repres
post
poct
implement
data
set
world
health
organis
describ
defin
daili
dose
ddd
assum
averag
mainten
dose
per
day
medicin
use
main
indic
adult
select
criteria
includ
adult
patient
confirm
diagnosi
influenza
type
b
multidisciplinari
team
review
medic
note
prescript
determin
gener
antibiot
name
dose
number
dose
cumul
dose
antibiot
administ
inpati
admiss
respect
cohort
period
accord
collabor
centr
drug
statist
methodolog
antibiot
consumpt
data
collat
analys
use
refer
valu
avail
anatom
therapeut
chemic
atc
classif
system
ddd
calcul
antimicrobi
consum
everi
patient
suitabl
cohort
entri
suitabl
statist
analysi
perform
use
microsoft
excel
add
xlstat
pvalu
consid
statist
signific
chi
squar
test
use
categor
data
total
patient
specimen
test
valid
phase
result
influenza
b
correl
present
addit
file
tabl
respect
one
discrep
result
instrument
influenza
repeat
analysi
nasal
throat
specimen
separ
genexpert
result
ct
valu
nasal
swab
throat
swab
neg
influenza
b
posit
patient
specimen
obtain
valid
period
extern
qualiti
control
scheme
sampl
intern
qualiti
control
sampl
posit
influenza
b
test
system
agreement
perform
characterist
valid
studi
present
addit
file
tabl
id
found
sensit
influenza
specif
influenza
b
obtain
sensit
specif
age
gender
profil
patient
cohort
screen
influenza
outlin
addit
file
tabl
patient
screen
season
femal
male
screen
season
averag
age
patient
screen
significantli
younger
pvalu
result
influenza
screen
retrospect
collat
season
evid
result
tabl
sampl
adult
year
influenzaposit
patient
chart
season
review
evprofil
patient
cohortalu
profil
defin
daili
dose
antibiot
administ
tabl
evid
result
signific
reduct
number
antibiot
dose
prescrib
versu
p
total
differ
antibiot
use
found
data
studi
indic
compel
posit
correl
poct
influenza
diagnost
earli
initi
target
antivir
therapi
indic
notabl
reduct
antimicrobi
consumpt
studi
cohort
studi
perform
id
flu
versu
genexpert
similar
previous
report
one
discord
specimen
found
low
viral
load
nasal
specimen
determin
threshold
cycl
ct
valu
obtain
genexpert
analysi
sampl
system
rule
swab
sampl
associ
bia
like
differ
method
associ
ct
cutoff
valu
typic
optimis
base
correl
viral
cultur
tcid
ml
tissu
cultur
infect
dose
valu
specif
viral
strain
consensu
clinic
relev
ct
cutoff
posit
specimen
would
use
assess
naat
poct
devic
season
peopl
ireland
influenza
hospitalis
peopl
need
admiss
critic
care
unit
total
peopl
notifi
influenza
die
incid
influenza
season
studi
patient
screen
amount
patient
screen
influenza
rel
admiss
also
similar
season
averag
age
patient
screen
influenza
drop
significantli
compar
uptak
influenza
vaccin
ireland
period
septemberdecemb
age
year
older
season
variat
vaccin
coverag
observ
age
group
highest
uptak
age
year
older
vaccin
statist
may
partli
explain
reduct
averag
age
patient
screen
influenza
infect
result
obtain
suggest
repeat
reduct
antibiot
consumpt
overal
studi
reproduc
attain
support
implement
robust
antimicrobi
stewardship
programm
introduct
abbott
id
influenza
test
pointofcar
hospit
medic
assess
unit
allow
identifi
issu
delay
diagnost
test
result
suspect
influenza
care
pathway
address
pointofcar
test
allow
implement
effect
effici
care
pathway
associ
reduc
hospit
stay
reduct
antibiot
consumpt
studi
larger
patient
popul
would
use
demonstr
reproduc
studi
potenti
lead
signific
cost
save
better
bed
manag
peak
influenza
season
effect
variabl
individu
prescrib
prefer
antibiot
laboratori
cultur
sensit
late
patient
present
hospit
statist
signific
antibiot
usag
pattern
varianc
cohort
note
supplementari
inform
accompani
paper
http
doi
addit
file
tabl
correl
id
genexpert
tabl
demograph
detail
patient
cohort
studi
figur
outlin
suspect
influenza
care
pathway
implement
studi
period
poct
pointofcar
test
naat
nucleic
acid
amplif
test
near
nick
enzym
nucleic
acid
restrict
vtm
viral
transport
medium
pcr
polymeras
chain
reaction
rt
revers
transcriptas
mau
medic
assess
unit
